跳至主要内容
临床试验/IRCT20230801059005N1
IRCT20230801059005N1招募中3 期

Evaluation the outcomes of major adverse cardiac events after six-month colchicine consumption in the patients with ST-elevation myocardial infarction that underwent primary percutaneous coronary intervention.

Shiraz University of Medical Sciences0 个研究点目标入组 204 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
入组人数
204

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
40 years 至 no limit(—)
性别
All

入选标准

  • Patients who had experienced ST-elevation myocardial infarction (STEMI)
  • In angiography of patients, in at least one of the epicardial arteries larger than or equal to two and a half millimeters, there should be a stenosis equal to or greater than fifty percent, which has been managed through percutaneous coronary intervention and medical therapy.
  • patients were undergoing percutaneous coronary intervention (PCI).

排除标准

  • 未提供

研究者

相似试验